139 related articles for article (PubMed ID: 15505428)
1. [Combined-modality therapy for locoregional esophageal cancer].
Kim SB
Korean J Gastroenterol; 2004 Oct; 44(4):179-85. PubMed ID: 15505428
[TBL] [Abstract][Full Text] [Related]
2. Multimodality therapy for esophageal cancer.
Refaely Y; Krasna MJ
Surg Clin North Am; 2002 Aug; 82(4):729-46. PubMed ID: 12472127
[TBL] [Abstract][Full Text] [Related]
3. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
6. New developments in the treatment of esophageal cancer.
Ilson DH
Clin Adv Hematol Oncol; 2004 Feb; 2(2):97-104. PubMed ID: 16163169
[TBL] [Abstract][Full Text] [Related]
7. Trimodality treatment versus surgery alone for esophageal cancer. A stratified analysis with minimally invasive pretreatment staging.
Jiao X; Sonett J; Gamliel Z; Doyle A; Schuetz J; Greenwald B; Suntharalingam M; Krasna MJ
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):531-7. PubMed ID: 12124569
[TBL] [Abstract][Full Text] [Related]
8. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy for esophageal cancer: current status and perspectives.
Ohtsu A
Int J Clin Oncol; 2004 Dec; 9(6):444-50. PubMed ID: 15616874
[TBL] [Abstract][Full Text] [Related]
10. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
[TBL] [Abstract][Full Text] [Related]
11. CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study.
van der Woude SO; Hulshof MC; van Laarhoven HW
Chin Clin Oncol; 2016 Feb; 5(1):13. PubMed ID: 26932437
[TBL] [Abstract][Full Text] [Related]
12. [Esophageal cancer: outcome according to therapeutic strategy].
Rousseau D; Capitain O; Denis F; Girault S; Poirier AL; Paumier A; Cellier P; Hamy A; Mahé MA; Mesgouez-Nebout N
Cancer Radiother; 2013 Feb; 17(1):10-20. PubMed ID: 23270680
[TBL] [Abstract][Full Text] [Related]
13. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant therapy for esophageal cancer: surgical considerations.
Piraino A; Vita ML; Tessitore A; Cusumano G; Congedo MT; Margaritora S; Porziella V; Meacci E; Cesario A; Granone P
Rays; 2006; 31(1):37-45. PubMed ID: 16999374
[TBL] [Abstract][Full Text] [Related]
15. [New strategies in the treatment of esophageal cancer].
Bidoli P; Aglione S; Toffolatti L; De Candis D; Bajetta E
Minerva Chir; 2002 Dec; 57(6):717-31. PubMed ID: 12592216
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic strategy for marginally resectable esophageal cancer].
Koyanagi K; Ozawa S
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1241-5. PubMed ID: 21829059
[TBL] [Abstract][Full Text] [Related]
17. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
Ohtsu A
Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of esophageal cancer].
Yang DH; Jung HY
Korean J Gastroenterol; 2008 Dec; 52(6):338-50. PubMed ID: 19096251
[TBL] [Abstract][Full Text] [Related]
19. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
20. Multimodality treatment of esophageal cancer: a review of the current status and future directions.
Ng T; Dipetrillo T; Purviance J; Safran H
Curr Oncol Rep; 2006 May; 8(3):174-82. PubMed ID: 16618381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
